Excelra | Value Evidence Services
Global Pharmaceuticals is poised to reach a trillion-dollar market by 2022 with an annual spend of $182 B on Research and Development. The global health economics and outcomes research (HEOR) market is expanding, driven by real-world evidence.
At Excelra we understand this!
Right from Value assessment to Value Realization, we help align regulatory, clinical evidence and reimbursement strategies, for product value, coverage, and market access.
View this video to learn more about our custom Value & Evidence services that encompass:
1. Outcomes research
2. Epidemiology modelling
3. Economic modelling
4. Value evidence communication
5. RWE & big data realization
6. SLR & meta-analysis